Diabetic gastroenteropathy: An underdiagnosed complication
Year: 2021
Type: review
Abstract: , hyperglycemia, vagal dysfunction, loss of expression of neural nitric oxide synthase in the myenteric plexus, alterations in the Cajal interstitial cell network, and oxidative stress). Gastrointestinal discomfort could be perceived 70% higher in diabetic patients, describing that 25% of diabetic patients experience gastrointestinal symptoms. Diabetic enteropathy could affect any portion of the gastrointestinal tract, but esophageal alterations were described in more than 60% of diabetic patients, also 60% of them present constipation, and 20%, diarrhea. Gastric emptying scintigraphy is useful to evaluate gastroparesis, therefore, gastric retention of more than 60% at 2 h has a sensitivity of 100% and specificity of 20% for diagnosis; however, other studies such as breath tests, with a sensitivity of 89% and a specificity of 80%, or the endoscopic capsule contribute to the diagnosis. There is no cure; however, management must be multidisciplinary, focused on slowing the progression of diabetic gastroenteropathy, reducing symptoms, and restoring function; that includes nutritional recommendation, maintain glucose levels kept below 180 mg/dL, use of prokinetics, anti-emetics; nowadays, it has been special interest in surgical treatment, such as pyloroplasty, also gastric electrical stimulation appears to be another alternative.
Source: World Journal of Diabetes
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: diabetic gastroparesis, esophageal dysfunction, constipation, diarrhea, gastric emptying scintigraphy, breath test, capsule endoscope, myenteric plexus, neuronal nitric oxide synthase, interstitial cells of Cajal, oxidative stress, hyperglycemia, vagal dysfunction, prokinetic agents, gastric electrical stimulation, pyloroplasty, multidisciplinary management
Open Access status: diamond
OpenAlex ID: W3171637415
